NYSE · Financial Statements
CBT (CBT) Financial Statements
$80.65
NYSE: CBT
Market Cap $4.16B
Overview Financials Dividend CBT most recently reported annual revenue of $3.7B, net profit of $331.0M, revenue has compounded at 7.3% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $3.4B $4.3B $3.9B $4.0B $3.7B Operating Profit $454.0M $389.0M $526.0M $614.0M $621.0M Net Profit $250.0M $209.0M $445.0M $380.0M $331.0M EPS $4.34 $3.62 $7.73 $6.72 $6.02 Op Margin 13.3% 9.0% 13.4% 15.4% 16.7%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $3.3B $3.5B $3.6B $3.7B $3.8B Total Liabilities $2.2B $2.5B $2.2B $2.1B $2.1B Cash $168.0M $206.0M $238.0M $223.0M $258.0M Borrowings $1.2B $1.5B $1.4B $1.3B $1.2B
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $257.0M $100.0M $595.0M $692.0M $665.0M Investing Cash Flow $-381.0M $-329.0M $-458.0M $-476.0M $-572.0M Financing Cash Flow $-22.0M $-75.0M $-140.0M $-199.0M $-225.0M Net Cash Flow $19.0M $36.0M $32.0M $-15.0M $35.0M Free Cash Flow $62.0M $-111.0M $351.0M $451.0M $391.0M
Valuation & Return Ratios
Metric Value PEG Ratio 1.00 EV / EBITDA 7.57 FCF Yield 10.02% Quick Ratio 0.96 Interest Coverage 8.17 Return 1Y 5.37% Return 3Y 23.97% Return 5Y 69.52%
Screens featuring this stock